Genomic Health (GHDX) to Release Quarterly Earnings on Monday

Genomic Health (NASDAQ:GHDX) is scheduled to announce its earnings results after the market closes on Monday, February 12th. Analysts expect the company to announce earnings of $0.08 per share for the quarter.

Genomic Health (NASDAQ:GHDX) last posted its quarterly earnings results on Wednesday, November 8th. The medical research company reported $0.03 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.01) by $0.04. The company had revenue of $83.82 million for the quarter, compared to the consensus estimate of $87.06 million. Genomic Health had a negative net margin of 1.30% and a negative return on equity of 1.79%. On average, analysts expect Genomic Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Shares of Genomic Health (NASDAQ GHDX) opened at $32.58 on Monday. Genomic Health has a 52-week low of $26.54 and a 52-week high of $37.50.

Several analysts recently weighed in on GHDX shares. Canaccord Genuity reiterated a “buy” rating and issued a $39.00 price objective on shares of Genomic Health in a research report on Wednesday, November 15th. BidaskClub upgraded shares of Genomic Health from a “sell” rating to a “hold” rating in a research report on Tuesday, December 19th. ValuEngine upgraded shares of Genomic Health from a “sell” rating to a “hold” rating in a research report on Friday, December 15th. Jefferies Group reiterated a “hold” rating and issued a $34.00 price objective on shares of Genomic Health in a research report on Friday, October 20th. Finally, Zacks Investment Research upgraded shares of Genomic Health from a “sell” rating to a “hold” rating in a research report on Friday, October 13th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and one has assigned a buy rating to the company. Genomic Health currently has an average rating of “Hold” and a consensus target price of $32.33.

In other Genomic Health news, insider James J. Vaughn sold 3,004 shares of the firm’s stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $34.09, for a total transaction of $102,406.36. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Kimberly J. Popovits sold 20,000 shares of the firm’s stock in a transaction dated Thursday, December 14th. The shares were sold at an average price of $31.50, for a total transaction of $630,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 74,338 shares of company stock worth $2,463,301. 46.20% of the stock is currently owned by insiders.

TRADEMARK VIOLATION WARNING: “Genomic Health (GHDX) to Release Quarterly Earnings on Monday” was published by Community Financial News and is the property of of Community Financial News. If you are accessing this report on another publication, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this report can be read at https://www.com-unik.info/2018/02/05/genomic-health-ghdx-to-release-quarterly-earnings-on-monday.html.

About Genomic Health

Genomic Health, Inc is a healthcare company that provides genomic-based diagnostic tests to personalize cancer treatment. The Company develops and commercializes genomic-based clinical laboratory services. The Company’s Oncotype IQ Genomic Intelligence Platform is consisted of its flagship line of Oncotype DX gene expression tests, as well as its Oncotype SEQ Liquid Select test.

Earnings History for Genomic Health (NASDAQ:GHDX)

Receive News & Ratings for Genomic Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genomic Health and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit